Cargando…

IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN

OBJECTIVE: To determine the clinical variances between strokes and stroke mimics in a pediatric immunocompromised population that consists of children with central nervous system (CNS) and non-CNS malignancies and a history of solid organ transplantation. METHODS: We performed a retrospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdi, Jasia, Bach, Alicia, Smith, Alyssa, Tomko, Stuart, Fields, Melanie, Griffith, Jennifer, Morris, Stephanie, Guerriero, Rejean, Noetzel, Michael, Guilliams, Kristin, Agner, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168258/
http://dx.doi.org/10.1093/neuonc/noab090.115
_version_ 1783701854370136064
author Mahdi, Jasia
Bach, Alicia
Smith, Alyssa
Tomko, Stuart
Fields, Melanie
Griffith, Jennifer
Morris, Stephanie
Guerriero, Rejean
Noetzel, Michael
Guilliams, Kristin
Agner, Shannon
author_facet Mahdi, Jasia
Bach, Alicia
Smith, Alyssa
Tomko, Stuart
Fields, Melanie
Griffith, Jennifer
Morris, Stephanie
Guerriero, Rejean
Noetzel, Michael
Guilliams, Kristin
Agner, Shannon
author_sort Mahdi, Jasia
collection PubMed
description OBJECTIVE: To determine the clinical variances between strokes and stroke mimics in a pediatric immunocompromised population that consists of children with central nervous system (CNS) and non-CNS malignancies and a history of solid organ transplantation. METHODS: We performed a retrospective cohort analysis of stroke alert activations in patients with high-grade gliomas, low-grade gliomas, atypical teratoid rhabdoid tumors, rare CNS tumors, B-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia, osteosarcoma, and solid organ transplants at St. Louis Children’s Hospital between February 2013 and September 2019. We categorized final diagnoses as strokes or stroke mimics. We classified diagnoses as a neurologic emergency if the diagnosis necessitated changes in management. RESULTS: Out of 217 stroke alerts, 31 alerts occurred for 28 patients meeting inclusion criteria. All final diagnoses constituted neurologic emergencies, including: stroke (39%), chemotherapy-related neurotoxicity (29%), tumor progression (19%), and seizures/posterior reversible encephalopathy syndrome (13%). Patients meeting inclusion criteria with strokes and stroke mimics presented similarly, with the exception of altered mental status, which was more prevalent in patients with strokes than stroke mimics (p = 0.03). One child received hyperacute thrombectomy for stroke. Only 58% of children with stroke mimics had complete resolution of their presenting neurologic symptoms. Children with strokes and stroke mimics had similar mortality incidences of 33% and 37%, respectively. CONCLUSIONS: Although all acute neurologic changes in immunocompromised children are not strokes, stroke mimics in this population are neither benign nor self-limited and carry long-term neurologic morbidity and mortality. This study highlights the utility of an acute stroke evaluation infrastructure and the need for acute and long-term neurology involvement in the care of these patients.
format Online
Article
Text
id pubmed-8168258
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81682582021-06-02 IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN Mahdi, Jasia Bach, Alicia Smith, Alyssa Tomko, Stuart Fields, Melanie Griffith, Jennifer Morris, Stephanie Guerriero, Rejean Noetzel, Michael Guilliams, Kristin Agner, Shannon Neuro Oncol Immunology/Immunotherapy OBJECTIVE: To determine the clinical variances between strokes and stroke mimics in a pediatric immunocompromised population that consists of children with central nervous system (CNS) and non-CNS malignancies and a history of solid organ transplantation. METHODS: We performed a retrospective cohort analysis of stroke alert activations in patients with high-grade gliomas, low-grade gliomas, atypical teratoid rhabdoid tumors, rare CNS tumors, B-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia, osteosarcoma, and solid organ transplants at St. Louis Children’s Hospital between February 2013 and September 2019. We categorized final diagnoses as strokes or stroke mimics. We classified diagnoses as a neurologic emergency if the diagnosis necessitated changes in management. RESULTS: Out of 217 stroke alerts, 31 alerts occurred for 28 patients meeting inclusion criteria. All final diagnoses constituted neurologic emergencies, including: stroke (39%), chemotherapy-related neurotoxicity (29%), tumor progression (19%), and seizures/posterior reversible encephalopathy syndrome (13%). Patients meeting inclusion criteria with strokes and stroke mimics presented similarly, with the exception of altered mental status, which was more prevalent in patients with strokes than stroke mimics (p = 0.03). One child received hyperacute thrombectomy for stroke. Only 58% of children with stroke mimics had complete resolution of their presenting neurologic symptoms. Children with strokes and stroke mimics had similar mortality incidences of 33% and 37%, respectively. CONCLUSIONS: Although all acute neurologic changes in immunocompromised children are not strokes, stroke mimics in this population are neither benign nor self-limited and carry long-term neurologic morbidity and mortality. This study highlights the utility of an acute stroke evaluation infrastructure and the need for acute and long-term neurology involvement in the care of these patients. Oxford University Press 2021-06-01 /pmc/articles/PMC8168258/ http://dx.doi.org/10.1093/neuonc/noab090.115 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Immunology/Immunotherapy
Mahdi, Jasia
Bach, Alicia
Smith, Alyssa
Tomko, Stuart
Fields, Melanie
Griffith, Jennifer
Morris, Stephanie
Guerriero, Rejean
Noetzel, Michael
Guilliams, Kristin
Agner, Shannon
IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
title IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
title_full IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
title_fullStr IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
title_full_unstemmed IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
title_short IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
title_sort immu-07. “stroke mimics” are not benign in immunocompromised children
topic Immunology/Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168258/
http://dx.doi.org/10.1093/neuonc/noab090.115
work_keys_str_mv AT mahdijasia immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT bachalicia immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT smithalyssa immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT tomkostuart immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT fieldsmelanie immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT griffithjennifer immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT morrisstephanie immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT guerrierorejean immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT noetzelmichael immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT guilliamskristin immu07strokemimicsarenotbenigninimmunocompromisedchildren
AT agnershannon immu07strokemimicsarenotbenigninimmunocompromisedchildren